These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 5774314)

  • 1. Advantages of aluminium hydroxide adsorbed combined diphtheria, tetanus, and pertussis vaccines for the immunization of infants.
    Butler NR; Voyce MA; Burland WL; Hilton ML
    Br Med J; 1969 Mar; 1(5645):663-6. PubMed ID: 5774314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency control of tetanus and diphtheria toxoids, adsorbed, produced in Bulgaria.
    Vrancheva S; Vulchev V; Bachev S
    Prog Immunobiol Stand; 1970; 4():548-52. PubMed ID: 5482199
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reactogenicity of adsorbed pertussis-diphtheria-tetanus vaccine with a parapertussi component].
    Men'shikova AK
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Oct; 44(10):85-9. PubMed ID: 5617226
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity and safety of a combined diphtheria, tetanus, acellular pertussis, and inactivated poliovirus vaccine (DTaP-IPV) compared to separate administration of standalone DTaP and IPV vaccines: a randomized, controlled study in infants in the Republic of Korea.
    Lee SY; Hwang HS; Kim JH; Kim HH; Lee HS; Chung EH; Park SE; Ma SH; Chang JK; Guitton F; Ortiz E; Kang JH
    Vaccine; 2011 Feb; 29(8):1551-7. PubMed ID: 21215828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IMMUNOGENICITY AND SAFETY OF QUINVAXEM® (DIPHTHERIA, TETANUS, WHOLE-CELL PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B VACCINE) GIVEN TO VIETNAMESE INFANTS AT 2 TO 4 MONTHS OF AGE.
    Huu TN; Phuong NT; Toan NT; Thang HV
    Southeast Asian J Trop Med Public Health; 2015 Jul; 46(4):753-63. PubMed ID: 26867396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New combined alum hydroxide adsorbed diphtheria-tetanus-pertussis-vaccine with parapertussis component. I. Reactogenicity and serological efficacy.
    Burián V; Kubátová E; Kratochvílová M; Buriánová-Vysoká B
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):143-7. PubMed ID: 5463707
    [No Abstract]   [Full Text] [Related]  

  • 7. Simultaneous immunization with B.C.G., diphtheria-tetanus, and oral poliomyelitis vaccines in children aged 13-14.
    Galbraith NS; Crosby G; Barnes JM; Fernandes R
    Br Med J; 1971 Apr; 2(5755):193-7. PubMed ID: 5575951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pertussis immunization of infants using a new combined DTP-polio vaccine.
    Drucker J; Schatzmayr H; Grenier B; Ajjan N; Peyron L; Roumiantzeff M
    Dev Biol Stand; 1985; 61():309-13. PubMed ID: 2872119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of combined diphtheria, tetanus and pertussis vaccines produced by different manufacturers, in laboratory animals and in infants.
    Nyerges G; Adám MM; Gács P; Ring R
    J Biol Stand; 1986 Jul; 14(3):241-7. PubMed ID: 3489716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse reactions after injection of adsorbed diphtheria-pertussis-tetanus (DPT) vaccine are not due only to pertussis organisms or pertussis components in the vaccine.
    Gupta RK; Relyveld EH
    Vaccine; 1991 Oct; 9(10):699-702. PubMed ID: 1759487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus.
    Adam E; Burian V; Kubátová E; Kratochvílovă M; Buriánov'A B; Kyselová M; Demelová M; Hejdová E
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):88-101. PubMed ID: 5462049
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reactions to adsorbed pertussis-diphtheria-tetanus vaccine].
    Zakharova MS; Vares AM; Vorob'eva AI; Ustinova VG
    Pediatriia; 1971 Jan; 50(1):65-8. PubMed ID: 5573533
    [No Abstract]   [Full Text] [Related]  

  • 14. Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.
    Aggerbeck H; Heron I
    Vaccine; 1995 Oct; 13(14):1360-5. PubMed ID: 8585294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ON THE EFFECT OF GAMMA-ALUMINUM HYDROXIDE AND GAMMA-ALUMINUM OXIDE ON THE ANTIGENIC ACTIVITY OF TETANUS TOXOID AND DIPHTHERIA TOXOID IN IMMUNIZATION EXPERIMENTS ON GUINEA PIGS].
    KOERNER L
    Z Hyg Infektionskr; 1964 Apr; 149():407-13. PubMed ID: 14214969
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. Recommendation of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1985 Dec; 103(6 ( Pt 1)):896-905. PubMed ID: 2998252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Booster vaccination against diphtheria and tetanus in man. Comparison of calcium phosphate and aluminium hydroxide as adjuvants--II.
    Aggerbeck H; Fenger C; Heron I
    Vaccine; 1995 Oct; 13(14):1366-74. PubMed ID: 8585295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Half-dose immunization for diphtheria, tetanus, pertussis: response of preterm infants.
    Bernbaum J; Daft A; Samuelson J; Polin RA
    Pediatrics; 1989 Apr; 83(4):471-6. PubMed ID: 2538797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.